Similar articles

• Anticoagulation is necessary in patients with atrial fibrillation after mitral valve replacement with bioprostheses.

  Rothlin ME. Rothlin ME. Z Kardiol. 1986;75 Suppl 2:317-20. Z Kardiol. 1986. PMID: 3727710 No abstract available.
• Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?

  ElBardissi AW, DiBardino DJ, Chen FY, Yamashita MH, Cohn LH. ElBardissi AW, et al. J Thorac Cardiovasc Surg. 2010 May;139(5):1137-45. doi: 10.1016/j.jtcvs.2009.10.064. Epub 2010 Mar 19. J Thorac Cardiovasc Surg. 2010. PMID: 20303508
• Do all patients with mechanical heart valve prostheses need anticoagulant therapy?

  Dale J, Nitter-Hauge S. Dale J, et al. Z Kardiol. 1986;75 Suppl 2:332-7. Z Kardiol. 1986. PMID: 3727714 No abstract available.
• Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.

  Colli A, Verhoye JP, Leguerrier A, Gherli T. Colli A, et al. Eur J Cardiothorac Surg. 2007 Apr;31(4):573-7. doi: 10.1016/j.ejcts.2007.02.002. Epub 2007 Feb 21. Eur J Cardiothorac Surg. 2007. PMID: 17317197 Review.
• Antithrombotic therapy following bioprosthetic aortic valve replacement.

  Nowell J, Wilton E, Markus H, Jahangiri M. Nowell J, et al. Eur J Cardiothorac Surg. 2007 Apr;31(4):578-85. doi: 10.1016/j.ejcts.2006.12.017. Epub 2007 Jan 30. Eur J Cardiothorac Surg. 2007. PMID: 17267235 Review.